ag真人平台官方
Other Affiliated Sites
Simplified Chinese
Traditional Chinese
ag真人平台官方:About Hepalink
ag真人平台官方:Group Profile
ag真人平台官方:Corporate Philosophy
Milestones
ag真人平台官方:Leadership Team
ag真人平台官方:Scientific Advisory Board
ag真人平台官方:Our Businesses
Heparin Business
ag真人平台官方:Global Industrial Chain
ag真人平台官方:Global Heparin Injections Business
Product Profile
ag真人平台官方:CDMO Services
ag真人平台官方:Innovative Drugs
ag真人平台官方:Global Manufacturing
ag真人平台官方:Company News
ag真人平台官方:Investor Relations
ag真人平台官方:Corporate Governance
ag真人平台官方:Disclosures
ag真人平台官方:Stock Information
ag真人平台官方:IR Events
ag真人平台官方:IR Contact
Join Us
ag真人平台官方:Career Development
ag真人平台官方:Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
ag真人平台官方:A-Share Information
ag真人平台官方:H-Share Information
ag真人平台官方:A-Share Information
ag真人平台官方:H-Share Information
2022.05.10
ag真人平台官方:关于对深圳证券交易所2021年年报问询函回复的公告
2022.05.05
DELAY IN DESPATCH OF 2021 ANNUAL REPORT
2022.05.05
2022 FIRST QUARTERLY REPORT
2022.05.05
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
2022.05.05
RESIGNATION OF EXECUTIVE DIRECTOR AND CHANGE OF FINANCIAL CONTROLLER
2022.04.30
第五届董事会第十八次会议决议公告
2022.04.30
关于董事辞职及财务总监变更的公告
2022.04.30
独立董事关于第五届董事会第十八次会议相关事项的独立意见
2022.04.30
2022年一季度报告
2022.04.27
关于举行2021年度网上业绩说明会的公告
第一页
上一页
20
21
22
23
24
下一页
最后一页
About Hepalink
ag真人平台官方:Group Profile
ag真人平台官方:Corporate Philosophy
Milestones
Leadership Team
ag真人平台官方:Scientific Advisory Board
Our Businesses
ag真人平台官方:Heparin Business
ag真人平台官方:CDMO Services
ag真人平台官方:Innovative Drugs
ag真人平台官方:Global Manufacturing
ag真人平台官方:Company News
Investor Relations
ag真人平台官方:Corporate Governance
ag真人平台官方:Disclosures
Stock Information
ag真人平台官方:IR Events
ag真人平台官方:IR Contact
Join Us
ag真人平台官方:Career Development
Contact Us
Official WeChat Account
ag真人平台官方:Legal Statement
·
ag真人平台官方:Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.